Literature DB >> 19828712

A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome.

Susan J van Dijk1, Edith J M Feskens, Marieke B Bos, Dianne W M Hoelen, Rik Heijligenberg, Mechteld Grootte Bromhaar, Lisette C P G M de Groot, Jeanne H M de Vries, Michael Müller, Lydia A Afman.   

Abstract

BACKGROUND: Changes in dietary fat composition could lower the risk of developing metabolic syndrome. Adipose tissue is an interesting tissue in this respect because of its role in lipid metabolism and inflammation.
OBJECTIVE: Our objective was to investigate the effect of a saturated fatty acid (SFA)- and a monounsaturated fatty acid (MUFA)-rich diet on insulin sensitivity, serum lipids, and gene expression profiles of adipose tissue in subjects at risk of metabolic syndrome.
DESIGN: A parallel controlled-feeding trial was conducted in 20 abdominally overweight subjects. Subjects received an SFA diet or a MUFA diet for 8 wk. Plasma and subcutaneous adipose tissue samples were obtained, and insulin sensitivity was measured by using a hyperinsulinemic-euglycemic clamp. Adipose tissue samples underwent whole-genome microarray and histologic analysis. Plasma and adipose tissue fatty acid composition and concentrations of serum cholesterol and plasma cytokine were determined.
RESULTS: Consumption of the SFA diet resulted in increased expression of genes involved in inflammation processes in adipose tissue, without changes in morphology or insulin sensitivity. The MUFA diet led to a more antiinflammatory gene expression profile, which was accompanied by a decrease in serum LDL-cholesterol concentrations and an increase in plasma and adipose tissue oleic acid content.
CONCLUSIONS: Consumption of an SFA diet resulted in a proinflammatory "obesity-linked" gene expression profile, whereas consumption of a MUFA diet caused a more antiinflammatory profile. This suggests that replacement of dietary SFA with MUFA could prevent adipose tissue inflammation and may reduce the risk of inflammation-related diseases such as metabolic syndrome. This trial was registered at clinicaltrials.gov as NCT00405197.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828712     DOI: 10.3945/ajcn.2009.27792

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  80 in total

Review 1.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

2.  Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity.

Authors:  Julia S El-Sayed Moustafa; Hariklia Eleftherohorinou; Adam J de Smith; Johanna C Andersson-Assarsson; Alexessander Couto Alves; Eleni Hadjigeorgiou; Robin G Walters; Julian E Asher; Leonardo Bottolo; Jessica L Buxton; Rob Sladek; David Meyre; Christian Dina; Sophie Visvikis-Siest; Peter Jacobson; Lars Sjöström; Lena M S Carlsson; Andrew Walley; Mario Falchi; Philippe Froguel; Alexandra I F Blakemore; Lachlan J M Coin
Journal:  Hum Mol Genet       Date:  2012-05-16       Impact factor: 6.150

3.  Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.

Authors:  Cecile Hryhorczuk; Marc Florea; Demetra Rodaros; Isabelle Poirier; Caroline Daneault; Christine Des Rosiers; Andreas Arvanitogiannis; Thierry Alquier; Stephanie Fulton
Journal:  Neuropsychopharmacology       Date:  2015-07-14       Impact factor: 7.853

4.  Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention.

Authors:  A Perez-Cornago; L Brennan; I Ibero-Baraibar; H H M Hermsdorff; A O'Gorman; M A Zulet; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2014-01-09       Impact factor: 4.158

5.  Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Authors:  Pablo Pérez-Martínez; Dimitri P Mikhailidis; Vasilios G Athyros; Mónica Bullo; Patrick Couture; María I Covas; Lawrence de Koning; Javier Delgado-Lista; Andrés Díaz-López; Christian A Drevon; Ramón Estruch; Katherine Esposito; Montserrat Fitó; Marta Garaulet; Dario Giugliano; Antonio García-Ríos; Niki Katsiki; Genovefa Kolovou; Benoît Lamarche; Maria Ida Maiorino; Guillermo Mena-Sánchez; Araceli Muñoz-Garach; Dragana Nikolic; José M Ordovás; Francisco Pérez-Jiménez; Manfredi Rizzo; Jordi Salas-Salvadó; Helmut Schröder; Francisco J Tinahones; Rafael de la Torre; Ben van Ommen; Suzan Wopereis; Emilio Ros; José López-Miranda
Journal:  Nutr Rev       Date:  2017-05-01       Impact factor: 7.110

6.  Dietary n-3 fatty acids significantly suppress lipogenesis in bovine muscle and adipose tissue: a functional genomics approach.

Authors:  Beate Hiller; Andrea Herdmann; Karin Nuernberg
Journal:  Lipids       Date:  2011-05-26       Impact factor: 1.880

7.  The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans.

Authors:  Vicencia Sales; Mary-Elizabeth Patti
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-09

8.  Postprandial interleukin-6 response in elderly with abdominal obesity and metabolic syndrome.

Authors:  P F P Moreira; M A Dalboni; M Cendoroglo; G M S Santos; M S Cendoroglo
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

9.  Depot-specific effects of treadmill running and rutin on white adipose tissue function in diet-induced obese mice.

Authors:  Neng Chen; Ting Lei; Lili Xin; Lingmei Zhou; Jinbo Cheng; Liqiang Qin; Shufen Han; Zhongxiao Wan
Journal:  J Physiol Biochem       Date:  2016-05-18       Impact factor: 4.158

Review 10.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.